Latanoprost
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2343 publications
Multimodal AI fuses proteomic and EHR data for rational prioritization of protein biomarkers in diabetic retinopathy.
Journal: medRxiv : the preprint server for health sciences
Published: April 01, 2026
Anterior Segment, Static and Dynamic Pupillography Changes in Patients with Primary Open-Angle Glaucoma Using Different Types of Topical Antiglaucomatous Agents.
Journal: Photodiagnosis and photodynamic therapy
Published: March 02, 2026
Lipidomic Analysis Reveals Drug-Induced Lipoxin Synthesis in Glaucoma Treatment.
Journal: JCI insight
Published: February 24, 2026
Sustained intraocular pressure lowering from suprachoroidal injection of a latanoprost lipid nanoparticle delivery system in the rabbit.
Journal: Frontiers in medicine
Published: December 28, 2025
The Role of EP3 Agonism in Intraocular Pressure-Lowering by Sepetaprost, a Novel Dual Agonist of FP and EP3 Receptors, in Monkeys.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: December 20, 2025
Phase III Prospective Randomised Study of Netarsudil and Concomitant Latanoprost Efficacy and Safety for Primary Open-Angle Glaucoma or Ocular Hypertension in Japan: J-ROCKET-2.
Journal: Advances in therapy
Published: December 08, 2025
Owner Obtained Intraocular Pressure Measurements in Canine Primary Angle Closure Glaucoma: A Pilot Study in 14 Dogs.
Journal: Veterinary ophthalmology
Published: November 20, 2025
Preclinical Evaluation of Safety and Efficacy of QLS-111: A Novel Formulation of an Adenosine Triphosphate-Sensitive Potassium Channel Opener.
Journal: Ophthalmology science
Published: November 14, 2025
Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan Sine®) with Latanoprost Eye Drops (Xalatan®) in the Treatment of Open-Angle Glaucoma and Ocular Hypertension.
Journal: Journal of clinical medicine
Published: November 11, 2025
Branded Compared with Generic Latanoprost in Glaucoma Therapy: Where Do We Stand?
Journal: Advances in therapy
Published: October 23, 2025
Long-Term Outcome of Endothelial Keratoplasty Among Glaucoma Patients and the Risk of Prostaglandin Analogue (Latanoprost) Use on Graft Rejection.
Journal: Journal of clinical medicine
Published: October 02, 2025
A prospective, randomized study comparing the effects of preservative-free latanoprost and preserved latanoprost eyedrops on MMP-9 expression and ocular surface disease index in glaucoma patients.
Journal: Japanese journal of ophthalmology
Published: September 17, 2025
Last Updated: 04/28/2026